Warfarin Recruiting Phase 4 Trials for Dabigatran (DB14726)

IndicationStatusPhase
DBCOND0034202 (Warfarin)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02979561Pradaxa or Warfarin for Prevention of Recurrent VTE in Patients With Angiographically Confirmed Acute Massive Pulmonary Embolism undergoIng Endovascular Mechanical Fragmentation and Thrombolytic TherapyTreatment